Dow Jones

44 910,65

0,42%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Menlo Therapeutics Inc (MNLO)
Menlo Therapeutics Inc (MNLO) Actualités

MNLO

Menlo Therapeutics (MNLO)

Menlo Therapeutics Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:MNLO

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
02/06/2023	22h35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MNLO	Menlo Therapeutics Inc
11/05/2023	22h25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MNLO	Menlo Therapeutics Inc
11/05/2023	22h22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/03/2023	22h14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:MNLO	Menlo Therapeutics Inc
25/11/2022	20h01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
18/11/2022	23h01	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/11/2022	22h51	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
28/07/2022	22h31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
12/05/2022	23h01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:MNLO	Menlo Therapeutics Inc
15/02/2022	12h40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/01/2022	23h22	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
21/06/2021	23h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MNLO	Menlo Therapeutics Inc
17/05/2021	12h30	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MNLO	Menlo Therapeutics Inc
06/05/2021	23h03	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:MNLO	Menlo Therapeutics Inc
20/04/2021	22h49	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
04/03/2021	22h32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MNLO	Menlo Therapeutics Inc
02/02/2021	21h17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MNLO	Menlo Therapeutics Inc
05/06/2020	22h35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:MNLO	Menlo Therapeutics Inc
22/05/2020	14h30	Business Wire	Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement	NASDAQ:MNLO	Menlo Therapeutics Inc
16/04/2020	18h47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
03/03/2020	22h05	GlobeNewswire Inc.	Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results	NASDAQ:MNLO	Menlo Therapeutics Inc
26/02/2020	13h30	GlobeNewswire Inc.	Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin	NASDAQ:MNLO	Menlo Therapeutics Inc
26/02/2020	01h01	GlobeNewswire Inc.	Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...	NASDAQ:MNLO	Menlo Therapeutics Inc
05/02/2020	14h30	GlobeNewswire Inc.	Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...	NASDAQ:MNLO	Menlo Therapeutics Inc
07/01/2020	22h49	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:MNLO	Menlo Therapeutics Inc
06/01/2020	22h48	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
16/12/2019	23h15	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
04/12/2019	23h20	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:MNLO	Menlo Therapeutics Inc
27/11/2019	14h00	GlobeNewswire Inc.	Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference	NASDAQ:MNLO	Menlo Therapeutics Inc
12/11/2019	23h09	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.	NASDAQ:MNLO	Menlo Therapeutics Inc